KOSDAQ Rises Over 5%, Triggering Buy-Side Circuit Breaker

iconKuCoinFlash
Share
AI summary iconSummary
The Fear and Greed Index reached extreme levels as the KOSDAQ index surged more than 5% on August 4, triggering a buy-side circuit breaker at 10:47:51 AM KST. This marked the third consecutive day and the 17th time this year that the mechanism was activated. Institutional investors net purchased 3,540 billion KRW in the KOSDAQ market, with trading volume reflecting strong market momentum.

BlockBeats news, August 4: This morning, South Korea’s KOSPI index performed weakly, while the KOSDAQ index rose strongly. The Korean exchange announced that at 10:47:51 AM (09:47 Beijing Time), it activated the buy-side circuit breaker (suspension of algorithmic trading) on the KOSDAQ market.


The KOSDAQ market has triggered buy-side circuit breakers for three consecutive trading days: on the 31st of last month, yesterday, and today. This marks the 17th occurrence this year, with 12 of those happening just last month. Strong institutional buying is driving the index higher. On today’s trading day, institutional investors net purchased 354 billion KRW on the KOSDAQ market, while retail and foreign investors net sold 167 billion KRW and 183 billion KRW, respectively.


Biotech stocks performed strongly, with Alteogen rising over 7%; LigaChem Biosciences gained 12.89%, ABL Bio rose 12.25%, HLB increased 9.55%, Peptron climbed 9.39%, and Sam Chun Dang Pharm advanced 6.00%. (Jin10)

Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.